Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $12.64 and traded as high as $13.54. Reckitt Benckiser Group shares last traded at $13.10, with a volume of 353,604 shares.
Analyst Ratings Changes
A number of brokerages have issued reports on RBGLY. Royal Bank of Canada reaffirmed an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Barclays lowered Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy”.
View Our Latest Report on RBGLY
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 11th will be issued a dividend of $0.2909 per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date is Friday, April 11th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Capture the Benefits of Dividend Increases
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.